186 related articles for article (PubMed ID: 38349538)
21. Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.
Bhatia S; Afanasiev O; Nghiem P
Curr Oncol Rep; 2011 Dec; 13(6):488-97. PubMed ID: 21953511
[TBL] [Abstract][Full Text] [Related]
22. Challenges documenting racial disparities in Merkel cell carcinoma.
Martin MR; Mohsin N; Vilasi S; Reed D; Brownell I
Cancer Biol Ther; 2022 Dec; 23(1):1-3. PubMed ID: 36404405
[TBL] [Abstract][Full Text] [Related]
23. Merkel Cell Carcinoma Therapeutic Update.
Cassler NM; Merrill D; Bichakjian CK; Brownell I
Curr Treat Options Oncol; 2016 Jul; 17(7):36. PubMed ID: 27262710
[TBL] [Abstract][Full Text] [Related]
24. Trends in incidence, treatment and survival of Merkel cell carcinoma in England 2004-2018: a cohort study.
Mistry K; Levell NJ; Hollestein L; Wakkee M; Nijsten T; Knott CS; Steven NM; Craig PJ; Venables ZC
Br J Dermatol; 2023 Feb; 188(2):228-236. PubMed ID: 36763882
[TBL] [Abstract][Full Text] [Related]
25. Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial.
D'Angelo SP; Bhatia S; Brohl AS; Hamid O; Mehnert JM; Terheyden P; Shih KC; Brownell I; Lebbé C; Lewis KD; Linette GP; Milella M; Georges S; Shah P; Ellers-Lenz B; Bajars M; Güzel G; Nghiem PT
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32414862
[TBL] [Abstract][Full Text] [Related]
26. Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel.
Spada F; Bossi P; Caracò C; Sileni VC; Dei Tos AP; Fazio N; Grignani G; Maio M; Quaglino P; Queirolo P; Ascierto PA;
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35701070
[TBL] [Abstract][Full Text] [Related]
27. Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer.
Akaike T; Nghiem P
J Dermatol Sci; 2022 Jan; 105(1):2-10. PubMed ID: 34836718
[TBL] [Abstract][Full Text] [Related]
28. Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up.
D'Angelo SP; Bhatia S; Brohl AS; Hamid O; Mehnert JM; Terheyden P; Shih KC; Brownell I; Lebbé C; Lewis KD; Linette GP; Milella M; Xiong H; Guezel G; Nghiem PT
ESMO Open; 2021 Dec; 6(6):100290. PubMed ID: 34715570
[TBL] [Abstract][Full Text] [Related]
29. Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma.
Asgari MM; Sokil MM; Warton EM; Iyer J; Paulson KG; Nghiem P
JAMA Dermatol; 2014 Jul; 150(7):716-23. PubMed ID: 24807619
[TBL] [Abstract][Full Text] [Related]
30. Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma.
Nghiem P; Bhatia S; Lipson EJ; Sharfman WH; Kudchadkar RR; Brohl AS; Friedlander PA; Daud A; Kluger HM; Reddy SA; Boulmay BC; Riker A; Burgess MA; Hanks BA; Olencki T; Kendra K; Church C; Akaike T; Ramchurren N; Shinohara MM; Salim B; Taube JM; Jensen E; Kalabis M; Fling SP; Homet Moreno B; Sharon E; Cheever MA; Topalian SL
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33879601
[TBL] [Abstract][Full Text] [Related]
31. Improved survival in women versus men with merkel cell carcinoma.
Tam M; Luu M; Barker CA; Gharavi NM; Hamid O; Shiao SL; Nguyen AT; Lu DJ; Ho AS; Zumsteg ZS
J Am Acad Dermatol; 2021 Feb; 84(2):321-329. PubMed ID: 32423829
[TBL] [Abstract][Full Text] [Related]
32. New perspectives in Merkel cell carcinoma.
Del Marmol V; Lebbé C
Curr Opin Oncol; 2019 Mar; 31(2):72-83. PubMed ID: 30694842
[TBL] [Abstract][Full Text] [Related]
33. Effect of radiation therapy on survival in patients with resected Merkel cell carcinoma: a propensity score surveillance, epidemiology, and end results database analysis.
Kim JA; Choi AH
JAMA Dermatol; 2013 Jul; 149(7):831-8. PubMed ID: 23864085
[TBL] [Abstract][Full Text] [Related]
34. Impact of Tumor-Infiltrating Lymphocytes on Overall Survival in Merkel Cell Carcinoma.
Butala AA; Jain V; Reddy VK; Sebro RA; Song Y; Karakousis G; Mitchell TC; Lukens JN; Shabason JE
Oncologist; 2021 Jan; 26(1):63-69. PubMed ID: 32886418
[TBL] [Abstract][Full Text] [Related]
35. Predictors of survival in neurometastatic Merkel cell carcinoma.
Harary M; Kavouridis VK; Thakuria M; Smith TR
Eur J Cancer; 2018 Sep; 101():152-159. PubMed ID: 30071443
[TBL] [Abstract][Full Text] [Related]
36. Immunotherapy in advanced Merkel cell carcinoma: Sydney west cancer network experience.
Hasmat S; Howle JR; Karikios DJ; Carlino MS; Veness MJ
J Med Imaging Radiat Oncol; 2021 Oct; 65(6):760-767. PubMed ID: 34053196
[TBL] [Abstract][Full Text] [Related]
37. [Update in treatment for Merkel Cell Carcinoma and clinical practice guide].
Tétu P; Baroudjian B; Madelaine I; Delyon J; Lebbé C
Bull Cancer; 2019 Jan; 106(1):64-72. PubMed ID: 30579571
[TBL] [Abstract][Full Text] [Related]
38. Current concepts and approaches to merkel cell carcinoma.
Babadzhanov M; Doudican N; Wilken R; Stevenson M; Pavlick A; Carucci J
Arch Dermatol Res; 2021 Apr; 313(3):129-138. PubMed ID: 32666149
[TBL] [Abstract][Full Text] [Related]
39. Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell Carcinoma.
Andruska N; Fischer-Valuck BW; Mahapatra L; Brenneman RJ; Gay HA; Thorstad WL; Fields RC; MacArthur KM; Baumann BC
JAMA Dermatol; 2021 May; 157(5):540-548. PubMed ID: 33760021
[TBL] [Abstract][Full Text] [Related]
40. Merkel cell carcinoma in Turkey: A multicentric study.
Yildiz F; Demirci U; Küçükarda A; Büyüksimsek M; Sakalar T; Topcu TO; Aslan F; Tufan G; Aydin O; Turna H; Babacan NA; Basoglu T; Kurt B; Yildiz B; Eren T; Demiray AG; Gumusay O; Arslan C; Özdemir N; Urun Y; Baykara M; Turan N; Uysal M; Bilici A; Kavgaci H; Çiçin İ; Kilickap S; Paydas S
J Cancer Res Ther; 2021; 17(6):1525-1529. PubMed ID: 34916389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
